Clinical Trial Update: Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update (KePreSt) assessing the effects of ketorolac and pregabalin in early-stage, estrogen receptor-positive breast cancer; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)
• Pregabalin (Pregabalin)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer | Phase 2 | Status: RECRUITING